Bryan Goldberg

Bio:

Bryan Goldberg is a commercial strategist with more than 20 years of experience across consulting, operations, sales, and insights in the pharmaceutical industry. He currently serves as Senior Director of Strategy and Operations at Pharmacosmos Therapeutics Inc., where he built and now leads a cross-functional department encompassing field operations, market insights, forecasting, incentive compensation, and new product planning. Since joining Pharmacosmos, Bryan has grown the team from one to nine, including two inside sales representatives, and established a commercial analytics infrastructure that supports strategic decision-making and business growth.

Bryan began his career at ZS Associates, where he advised pharmaceutical and biotech clients on segmentation, forecasting, and go-to-market strategy. He then joined Sanofi-Aventis in a field operations role before taking on successive commercial positions at Biogen—first in headquarters operations, then in the field as a top-performing Territory Business Manager in multiple sclerosis. He later held leadership roles at Intercept Pharmaceuticals, where he led sales operations and supported cross-functional prelaunch and performance initiatives.

Bryan holds an MBA from Duke University’s Fuqua School of Business and a BA in Biophysics and Physics from the University of Pennsylvania. His experience spans oncology, neurology, hepatology, and rare disease, and he brings a uniquely well-rounded perspective that bridges strategic planning with hands-on execution.